m+Medelevator.RU
← Поиск публикаций
Actas urologicas espanolas · 2026

Impact of intravesical BCG Therapy on quality of life in non-muscle-invasive bladder cancer: a prospective evaluation using the FACT-Bl questionnaire.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Caño-Velasco J, Luis-Cardo A, Moreno-Cortés J C, Carrasco-Loras L, Astudillo-Campoverde J, Subiela J D, Lozano-Palacio F, Campistol-Torres M, Pichler R, Partl A, Lackner F, Giudice F Del, Carino D, García-Martín L A, Salamanca-Blanco P, Bielsa-Carrillo A, Pastor-Cordero A M, Bataller-Monfort V, Tello-Delsors A, Polanco-Pujol L, Lafuente-Puentedura A, Aragón-Chamizo J, Herranz-Amo F, Barbas-Bernardos G, González-Padilla D A, Villacampa-Aubá F, Sánchez-Zalabardo D, Robles-García J E, Miñana-López B, Moschini M, Soria F, D'Andrea D, Mertens L S, Teoh J Y C, Albisinni S, Pradere B, Hernández-Fernández C, en nombre de la Asociación Europea de Urología - Jóvenes Urólogos Académicos (EAU-YAU), Grupo de Trabajo Sobre Carcinoma Urotelial

Аннотация

INTRODUCTION AND OBJECTIVE: Intravesical bacillus Calmette-Guérin(BCG) remains the standard treatment for high-risk non-muscle-invasive bladder cancer(NMIBC) and is also considered an option for intermediate and very high-risk groups. Despite over five decades of clinical use, limited information is available regarding patients' quality of life(QoL) during therapy. The objective was to evaluate QoL patients receiving BCG therapy using the Functional Assessment of Cancer Therapy-Bladder Cancer(FACT-Bl) questionnaire.

MATERIALS AND METHODS: Prospective multicentre observational study from February 2022 to June 2024 in patients with NMIBC. Patients completed the FACT-Bl questionnaire before and after the induction course. The results of both questionnaires were compared with Student's t-test for paired data using IBM®SPSS-Statistics-25.

RESULTS: A total of 235 patients completed both questionnaires and were analysed. 97% of the series completed BCG induction. A worsening in the physical well-being(PWB) subscale(P < 0.05) and an improvement in the emotional well-being(EWB) subscale(P < 0.05) were observed in the total series of cases, without differences in total scores. In BCG-naive patients (90%), significant deterioration was observed in PWB subscale(P < 0.05) and FACT-Bl Trial Outcome Index(TOI) (P < 0.05). Patients over 75 years showed a statistically significant improvement in EWB, while those aged ≤75 years experienced significant declines in PWB, bladder cancer subscale (BlCS), and three total scores. Limitations include exclusive use of FACT-Bl questionnaire to assess QoL and limited sample size.

CONCLUSIONS: BCG induction therapy shows no significant impact on overall FACT-Bl scores but declines PWB and improves EWB subscales. Age and prior BCG exposure influence outcomes; notably, patients aged ≤75 show marked declines in PWB, BlCS and total FACT-Bl scores.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты